Preliminary scientific studies indicate conolidine might inhibit unique ion channels, lowering neuronal excitability and limiting ache signals. This mechanism is particularly applicable in neuropathic pain, wherever abnormal signaling causes persistent pain. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to pai